Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2006-05-30
2006-05-30
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
C514S148000, C514S227500, C514S237500, C514S325000, C514S369000, C514S381000, C514S517000, C514S531000, C514S532000, C514S538000, C514S563000, C514S575000, C514S577000, C514S621000, C514S623000, C514S624000, C544S059000, C544S154000, C546S203000, C548S183000, C548S252000, C558S044000, C558S051000, C558S058000, C558S177000, C564S161000, C564S170000, C564S171000, C564S176000
Reexamination Certificate
active
07053071
ABSTRACT:
The present invention provides compounds that are inducers or inhibitors of apoptosis or apoptosis preceded by cell-cycle arrest. In addition, the present invention provides pharmaceutical compositions and methods for treating mammals with leukemia or other forms of cancer or for treating disease conditions caused by apoptosis of cells.
REFERENCES:
patent: 4680299 (1987-07-01), Hesson
patent: 6127415 (2000-10-01), Pfahl et al.
patent: 6462064 (2002-10-01), Pfahl et al.
patent: 6515003 (2003-02-01), Pfahl et al.
patent: 6627656 (2003-09-01), Gallant et al.
patent: 2002/0143182 (2002-10-01), Pfahl et al.
patent: 0947496 (1999-10-01), None
patent: 10-20514 (1998-01-01), None
patent: WO 97/32853 (1997-09-01), None
patent: WO-98/01132 (1998-01-01), None
patent: WO 01/36365 (2001-05-01), None
patent: WO-01/56563 (2001-08-01), None
patent: WO-03/011808 (2003-02-01), None
Hawley's Condensed Chemical Dictionary, 12th ed., Richard J. Lewis, Sr., © 1993 by Van Nostrand Reinhold, p. 594.
Concise Chemical Dictionary, edited by Drs. Hans-Dieter Jakubke and Hans Jeschkeit, © 1993 by Walter de Gruyter & Co., p. 490.
McGraw-Hill Dictionary of Chemical Terms, 3rd ed. edited by Sybil P. Parker, © 1984 McGraw-Hill, Inc., p. 200.
U.S. Appl. No. 60/199,299 (Gallant et al), filed Apr. 24, 2000.
Benincori et al, “Rearrangements of Aromatic Carbonyl Arylhydrazones of Benzene, Naphthalene, and Azulene” J. Chem. Soc. Perking Transactions I., vol. 10, pp. 2721-2728 (1988).
Brunow and Ilus, “Reaction of 2,6-di-tert-butyl-4-propionylphenoxy radicals with ethyl ferulate” Tetrahedron Letters, vol. 10, pp. 711-712 (1970). AS ABSTRACTED BY CAPLUS.
Garcia-Conesa et al, “Ferulic acid dehydrodimers from wheat bran: isolation, purification and antioxidant properties of 8-O-4-diferulic acid” Redox Report, vol. 3(5/6) pp. 319-323 (1997). AS ABSTRACTED BY CAPLUS.
Aravind, L., et al., “Apoptotic Molecular Machinery: Vastly Increased Complexity in Vertebrates Revealed by Genome Comparisons”,Science Magazine, 291, (Feb. 2001), 1279-1284.
Bennett, John M., et al., “Proposed Revised Criteria for the Classification of Acute Myeloid Leukemia”,Annals of Internal Medicine, 103, (1985),626-629.
Berman, Ellin, “Recent Advances in the Treatment of Acute Leukemia: 1999”,Current Opinions in Hematology, 4,(2000),205-211.
Bernard, Bruno A., et al., “Identification of Synthetic Retinoids with Selectivity for Human Nuclear Retinoic Acid Receptor”,Biochemical and Biophysical Research Communications, 186, (1992),977-983.
Boise, Lawrence H., et al., “bcl-x, a bcl-2-Related Gene That Functions as a Dominant Regulator of Apoptotic Cell Death”,Cell, 74, (1993),597-608.
Bradner, William T., et al., “Myeloid Leukemia C1498 as a Screen for Cancer Chemotherapeutic Agents”,Cancer Research, 26, (1966),375-390.
Breitman, T. R., et al., “Terminal Differentiation of Human Promyelocytic Leukemic Cells in Primary Culture in Response to Retinoic Acid”,Blood, 57, 6, (1981),1000-1004.
Bruserud, Oystein, et al., “New Strategies for the Treatment of Acute Myelogenous Leukemia: Differentiation Induction-Present Use and Future Possibilities”,Stem Cells, 18, (2000),57-165.
Bruserud, Oystein, et al., “New Strategies in the Treatment of Acute Myelogenous Leukemia: Mobilization and Transplantation of Autologous Peripherial Blood Stem Cells in Adult Patients”,Stem Cells, 18, (2000),343-351.
Castaigne, Sylvie, et al., “All-Trans Retinoic Acid as a Differentiation Therapy for Acute Promyelocytic Leukemia. I. Clinical Results”,Blood, 76, 9, (Nov. 1990),1704-1709.
Chao, W. R., et al., “Effects of Receptor Class- and Subtype-Selective Retinoids and an Apoptosis-Inducing Retinoid on the Adherent Growth of the NIH:OVCAR-3 Ovarian Cancer Cell Line in Culture”,Cancer Letters, 115, (1997),1-7.
Chen, Zi-Xing, et al., “A Clinical and Experimental Study on All-Trans Retinoic Acid-Treated Acute Promyelocytic Leukemia Patients”,Blood, 78, 6,(1991),1413-1419.
Corbett, Thomas H., et al., “Preclinical Efficacy of Thioxanthone SR271425 Against Transplanted Solid Tumors of Mouse and Human Origin”,In: Investigational New Drugs, 17, Kluwer Academic Publishers, Netherlands,(1999),7-27.
Corbett, Thomas, et al., “Tumor Models and the Discovery and Secondary Evaluation of Solid Tumor Active Agents”,International Journal of Pharmacognosy, 33, (1995),102-122.
Davis, Roger J., “Signal Transduction by the JNK Group of MAP Kinases”,Cell, 103, (2000),239-252.
Franklin, R. A., et al., “Kinases: Positive and Negative Regulators of Apoptosis”,Leukemia, 14, (2000),2019-2034.
Fujita, Naoya, et al., “Acceleration of Apoptotic Cell Death after the Cleavage of Bcl-X(L) Protein by Caspase-3-like Proteases”,Oncogene, 17, (1998),1295-1304.
Gavrieli, Y., “Identification of Programmed Cell Death In Situ via Specific Labeling of Nuclear DNA Fragmentation”,The Journal of Cell Biology, 119(3), (Nov. 1992),pp. 493-501.
Gross, Atan, et al., “BCL-2 Family Members and the Mitochondria in Apoptosis”,Genes and Development, 13, (1999),1899-1911.
Hanada, Motoi, et al., “bcl-2 Gene Hypomethylation and High-Level Expression in B-Cell Chronic Lymphocytic Leukemia”,Blood, 82, 6, (1993),1820-1828.
Hsu, C. A., et al., “Retinoid Induced Apoptosis in Leukemia Cells Through a Retinoic Acid Nuclear Receptor-Independent Pathway”,Blood, 89, 12, (1997),4470-4479.
Jarpe, Matthew B., et al., “Anti-apoptotic Versus Pro-apoptotic Signal Transduction: Checkpoints and stop signs along the road to death”,Oncogene, 17, (1998),1475-1482.
Lazebnik, Y. A., et al., “Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE”,Nature, 371, (Sep. 1994),346-347.
Parchment, Ralph E., et al., “In Vivo-In Vitro Correlation of Myelotoxicity of 9-Methoxypyrazoloacridine (NSC-366140, PD115934) to Myeloid and Erythroid Hematopoietic Progenitors From Human, Murine, and Canine Marrow”,Journal of the National Cancer Institute, 86, 4, (Feb. 1994),273-280.
Saez, Ruben A., “Therapeutic Options in the Management of Acute Myelogenous Leukemia in Adults”,Cancer Control Journal of the Moffitt Cancer Center, 4, 5, (1997),13 pgs.
Shao, Zhi-Ming, et al., “p53 Independent G(0)/G(1) Arrest and Apoptosis Induced by a Novel Retinoid in Human Breast Cancer Cells”,Oncogene, 11, (1995),493-504.
Sharpless, T., et al., “Flow Cytofluorimetry: Discrimination Between Single Cells and Cell Aggregates by Direct Size Measurements”,Acta Cytologica, 19, 6, (1975),577-581.
Sheikh, M. S., et al., “Mechanisms of Regulation of WAF1/Cip1 Gene Expression in Human Breast Carcinoma: Role of p53-dependent and Independent Signal Transduction Pathways”,Oncogene, 9, (1994),3407-3415.
Stein, A. S., et al., “High-dose Cytosine Arabinoside and Daunorubicin Induction Therapy for Adult Patients with de novo Non M3 Acute Myelogenous Leukemia: Impact of Cytogenetics on Achieving a Complete Remission”,Leukemia, 14, (2000),1191-1196.
Teicher, Beverly A., “In Vivo Tumor Response End Points”,In: Tumor Models in Cancer Research, B. A. Teicher, ed., Humana Press, Totowa, New Jersey,(2002),593-616.
Thacker, J. D., et al., “Cytokine-Dependent Engraftment of Human Myeloid Leukemic Cell Lines in Immunosuppressed Nude Mice”,Leukemia, 8, 5, (1994),871-877.
Thomas, Anju, et al., “Drug-induced Apoptosis in B-cell Chronic Lymphocytic Leukemia: Relationship Between p53 Gene Mutation and bcl-2/bax Proteins in Drug Resistance”,Oncogene, 12, (1996),1055-1062.
Tournier, Cathy, et al., “Requirement of JNK for Stress-Induced Activation of the Cytochrome c-Mediated Death Pathway”,Science, 288, (2000),870-874.
Vaux, D. L., et al., “The Molecular Biology of Apoptosis”,Proceed
Dawson Marcia
Fontana Joseph A.
Hobbs Peter D.
Jong Ling
Leid Mark
Schwegman Lundberg Woessner & Kluth P.A.
The Burnham Institute
Tucker Zachary C.
Wilson James O.
LandOfFree
Induction of apoptosis in cancer cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Induction of apoptosis in cancer cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Induction of apoptosis in cancer cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3575711